While the COVID-19 pandemic quickly reversed decades of progress in closing the gap between life expectancies for Black and white people in the United States, the disease’s toll may have obscured the impact of another significant public health concern -; a sharp increase in homicide rates -; on the life expectancy of Black men, according to researchers at the University of Wisconsin–Madison.
Bayer expands Kerendia heart failure program to 15,000 patients as it plans to start three Phase III trials
Bayer is working on expanding the label for its chronic kidney disease drug Kerendia, announcing three new trials to investigate it as a treatment for
September 2, 2023